US Equity
XNCR
— XENCOR, INC.Xencor, Inc. is a clinical-stage biopharmaceutical company that develops engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases.
💰 Market cap: $1.47B📍 465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107 US🏷️ Biotechnology & Medical Research💵 Previous close: $19.44🔢 8,688 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $19.44 |
| 2026-07-23 | $19.53 |
| 2026-07-22 | $19.51 |
| 2026-07-21 | $20.45 |
| 2026-07-20 | $18.81 |
| 2026-07-17 | $17.47 |
| 2026-07-16 | $14.95 |
| 2026-07-15 | $14.98 |
| 2026-07-14 | $14.95 |
| 2026-07-13 | $14.96 |
| 2026-07-10 | $15.85 |
| 2026-07-09 | $16.11 |
| 2026-07-08 | $16.46 |
| 2026-07-07 | $15.67 |
| 2026-07-06 | $14.89 |
| 2026-07-02 | $15.00 |
| 2026-07-01 | $15.38 |
| 2026-06-30 | $16.10 |
| 2026-06-29 | $15.60 |
| 2026-06-26 | $15.05 |
| 2026-06-25 | $14.74 |
| 2026-06-24 | $14.45 |
| 2026-06-23 | $14.08 |
| 2026-06-22 | $14.01 |
| 2026-06-18 | $12.64 |
| 2026-06-17 | $12.78 |
| 2026-06-16 | $12.20 |
| 2026-06-15 | $12.21 |
| 2026-06-12 | $12.33 |
| 2026-06-11 | $12.09 |
| 2026-06-10 | $11.83 |
| 2026-06-09 | $11.89 |
| 2026-06-08 | $11.41 |
| 2026-06-05 | $11.77 |
| 2026-06-04 | $12.01 |
| 2026-06-03 | $11.42 |
| 2026-06-02 | $11.21 |
| 2026-06-01 | $11.80 |
| 2026-05-29 | $11.88 |
| 2026-05-28 | $11.97 |
| 2026-05-27 | $11.72 |
| 2026-05-26 | $11.63 |
| 2026-05-22 | $11.31 |
| 2026-05-21 | $11.27 |
| 2026-05-20 | $11.32 |
| 2026-05-19 | $10.41 |
| 2026-05-18 | $11.06 |
| 2026-05-15 | $11.22 |
| 2026-05-14 | $11.88 |
| 2026-05-13 | $12.38 |
| 2026-05-12 | $12.44 |
| 2026-05-11 | $12.79 |
| 2026-05-08 | $12.86 |
| 2026-05-07 | $12.31 |
| 2026-05-06 | $13.01 |
| 2026-05-05 | $12.85 |
| 2026-05-04 | $13.36 |
| 2026-05-01 | $12.69 |
| 2026-04-30 | $11.93 |
| 2026-04-29 | $11.62 |
| 2026-04-28 | $12.15 |